76 related articles for article (PubMed ID: 17869221)
21. p53-catalyzed annealing of complementary single-stranded nucleic acids.
Oberosler P; Hloch P; Ramsperger U; Stahl H
EMBO J; 1993 Jun; 12(6):2389-96. PubMed ID: 7685274
[TBL] [Abstract][Full Text] [Related]
22. Multivalent helix mimetics for PPI-inhibition.
Barnard A; Miles JA; Burslem GM; Barker AM; Wilson AJ
Org Biomol Chem; 2015 Jan; 13(1):258-64. PubMed ID: 25408290
[TBL] [Abstract][Full Text] [Related]
23. Removal of nonspecific binding proteins is required in co-immunoprecipitation with nuclear proteins.
Zeng X; Zeng WH; Zhou J; Liu XM; Huang G; Zhu H; Xiao S; Zeng Y; Cao D
Biotechniques; 2022 Dec; 73(6):289-296. PubMed ID: 36401550
[TBL] [Abstract][Full Text] [Related]
24. Preface.
Lin RJ
Methods Mol Biol; 2016; 1421():vii-viii. PubMed ID: 27403468
[No Abstract] [Full Text] [Related]
25. An Extended DNA Binding Domain of the Estrogen Receptor Alpha Directly Interacts with RNAs
Steiner HR; Lammer NC; Batey RT; Wuttke DS
Biochemistry; 2022 Nov; 61(22):2490-2494. PubMed ID: 36239332
[TBL] [Abstract][Full Text] [Related]
26. Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions.
Shen Y; Liu S; Fan J; Jin Y; Tian B; Zheng X; Fu H
EMBO Rep; 2017 Apr; 18(4):536-548. PubMed ID: 28264987
[TBL] [Abstract][Full Text] [Related]
27. p53, a translational regulator: contribution to its tumour-suppressor activity.
Marcel V; Catez F; Diaz JJ
Oncogene; 2015 Oct; 34(44):5513-23. PubMed ID: 25728674
[TBL] [Abstract][Full Text] [Related]
28. The aggregation of mutant p53 produces prion-like properties in cancer.
Rangel LP; Costa DC; Vieira TC; Silva JL
Prion; 2014; 8(1):75-84. PubMed ID: 24509441
[TBL] [Abstract][Full Text] [Related]
29. Cooperativity dominates the genomic organization of p53-response elements: a mechanistic view.
Pan Y; Nussinov R
PLoS Comput Biol; 2009 Jul; 5(7):e1000448. PubMed ID: 19629163
[TBL] [Abstract][Full Text] [Related]
30. Binding of RNA to p53 regulates its oligomerization and DNA-binding activity.
Yoshida Y; Izumi H; Torigoe T; Ishiguchi H; Yoshida T; Itoh H; Kohno K
Oncogene; 2004 May; 23(25):4371-9. PubMed ID: 15064727
[TBL] [Abstract][Full Text] [Related]
31. RNA-p53 interactions in vitro.
Riley KJ; Ramirez-Alvarado M; Maher LJ
Biochemistry; 2007 Mar; 46(9):2480-7. PubMed ID: 17288451
[TBL] [Abstract][Full Text] [Related]
32. Analysis of p53-RNA interactions in cultured human cells.
Riley KJ; James Maher L
Biochem Biophys Res Commun; 2007 Nov; 363(2):381-7. PubMed ID: 17869221
[TBL] [Abstract][Full Text] [Related]
33. Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.
Riley KJ; Cassiday LA; Kumar A; Maher LJ
RNA; 2006 Apr; 12(4):620-30. PubMed ID: 16581806
[TBL] [Abstract][Full Text] [Related]
34. p53 RNA interactions: new clues in an old mystery.
Riley KJ; Maher LJ
RNA; 2007 Nov; 13(11):1825-33. PubMed ID: 17804642
[TBL] [Abstract][Full Text] [Related]
35. An intact sequence-specific DNA-binding domain is required for human cytomegalovirus-mediated sequestration of p53 and may promote in vivo binding to the viral genome during infection.
Rosenke K; Samuel MA; McDowell ET; Toerne MA; Fortunato EA
Virology; 2006 Apr; 348(1):19-34. PubMed ID: 16455125
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
